PMI Stock: Price, Forecast, Financials & AI Analysis

Loading...

Loading chart...

High

0.957

Open

0.940

VWAP

0.94

Vol

114.44K

Mkt Cap

71.19M

Low

0.902

Amount

107.31K

EV/EBITDA(TTM)

--

Total Shares

75.18M

EV

70.30M

EV/OCF(TTM)

--

P/S(TTM)

14.00

Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.

Show More

Events Timeline

(ET)

2026-03-19

08:30:00

Picard Medical Highlights Successful Heart Transplant Case Using Total Artificial Heart

2026-02-12 (ET)

2026-02-12

08:50:00

Picard Medical Announces UCSF's First Heart Transplant Success

2026-01-12 (ET)

2026-01-12

11:10:00

Company Not Selling Common Stock, No Proceeds Received

2026-01-12

09:10:00

Picard Medical Partners with Hydrix to Develop Next-Gen Artificial Heart Technology

2026-01-06 (ET)

2026-01-06

08:10:00

Picard Medical Introduces New Design Component for SynCardia Total Artificial Heart

2025-12-02 (ET)

2025-12-02

07:30:00

PMI Confirms 2025 Full-Year Diluted EPS Forecast of $7.39 to $7.49

News

Newsfilter

04-16Newsfilter

PinnedPicard Medical Participates in ISHLT 2026 Annual Meeting

Globenewswire

04-13Globenewswire

Class Action Lawsuit Reminder Against Picard Medical, Inc.

PRnewswire

04-10PRnewswire

Faruqi & Faruqi Encourages Picard Medical Investors to Reach Out

Globenewswire

04-09Globenewswire

Picard Medical Securities Class Action Reminder

Globenewswire

04-07Globenewswire

Picard Medical Securities Class Action Notice

PRnewswire

04-04PRnewswire

Faruqi & Faruqi Encourages Picard Medical Investors to Reach Out

Valuation Metrics

The current forward P/E ratio for Picard Medical Inc (PMI.A) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess Picard Medical Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

dotted line Image

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

dotted line Image

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

dotted line Image

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

AI Analysis

Annual

Quarterly

Whales Holding PMI

Trading Trends

People Also Watch

Frequently Asked Questions

What is Picard Medical Inc (PMI) stock price today?

The current price of PMI is 0.9535 USD — it has increased 0.74

What is Picard Medical Inc (PMI)'s business?

Picard Medical, Inc. is a holding company that owns a 100% interest in SynCardia Systems, LLC (SynCardia). SynCardia is a medical technology company that manufactures and sells the only United States Food and Drug Administration (FDA) and Health Canada-approved implantable total artificial heart (SynCardia TAH). The SynCardia TAH is a biventricular replacement device that consists of the SynCardia TAH implant, an external pneumatic driver that delivers precisely calibrated pulses of air to drive the implant, and drivelines that connect the driver to the implant. The SynCardia TAH implant is a system that consists of two independent artificial ventricles which are powered by an external pneumatic driver. Each artificial ventricle is made of a semi-rigid polyurethane housing and a rigid polyurethane base, with a four-layer flexible polyurethane diaphragm separating the blood chamber from the air chamber.

What is the price predicton of PMI Stock?

Wall Street analysts forecast PMI stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for PMI is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Picard Medical Inc (PMI)'s revenue for the last quarter?

Picard Medical Inc revenue for the last quarter amounts to 1.01M USD, increased 20.69

What is Picard Medical Inc (PMI)'s earnings per share (EPS) for the last quarter?

Picard Medical Inc. EPS for the last quarter amounts to -0.06 USD, decreased -53.85

How many employees does Picard Medical Inc (PMI). have?

Picard Medical Inc (PMI) has 75 emplpoyees as of April 17 2026.

What is Picard Medical Inc (PMI) market cap?

Today PMI has the market capitalization of 71.19M USD.